Skip to main content

Advertisement

Log in

Heroin overdose: Research and evidence-based intervention

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

Drug overdose is a major cause of premature death and morbidity among heroin users. This article examines recent research into heroin overdose to inform interventions that will reduce the rate of overdose death. The demographic characteristics of overdose cases are discussed, including factors associated with overdose: polydrug use, drug purity, drug tolerance, routes of administration, and suicide. Responses by heroin users at overdoses are also examined. Potential interventions to reduce the rate of overdose and overdose-related morbidity are examined in light of the emerging data in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fugelstad A, Annell A, Rajs J, Angren G. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatr Scand. 1997;96:169–175.

    CAS  PubMed  Google Scholar 

  2. Goldstein A, Herrara J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 1995;40:139–150.

    Article  CAS  PubMed  Google Scholar 

  3. Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22 year follow-up. Addiction. 1994;89:1299–1308.

    Article  CAS  PubMed  Google Scholar 

  4. Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P. Study of 2708 heroin-related deaths in north-eastern Italy 1985–98 to establish main causes of death. Addiction. 2001;96:1127–1137.

    Article  CAS  PubMed  Google Scholar 

  5. Sanchez-Carbonell X, Seus L. Ten year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST project. Addiction. 2000;95:941–948.

    Article  CAS  PubMed  Google Scholar 

  6. Darke S, Zador D. Fatal heroin overdose: a review. Addiction. 1996;91:1765–1772.

    Article  CAS  PubMed  Google Scholar 

  7. Sporer K. Acute heroin overdose. Ann Int Med. 1999;130:584–590.

    CAS  PubMed  Google Scholar 

  8. Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96:1113–1125.

    Article  CAS  PubMed  Google Scholar 

  9. Centers for Disease Control. Heroin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636.

    Google Scholar 

  10. Centers for Disease Control. Unintentional opiate overdose deaths—Kings County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49:636–640.

    Google Scholar 

  11. Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26:453–460.

    Article  CAS  PubMed  Google Scholar 

  12. O’Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Russell AE. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health. 2001;26:984–987.

    Google Scholar 

  13. Hall W, Degenhardt L, Lynskey M. Trends in opioid overdose and suicide mortality in young adults in Australia 1964–1997. Med J Aust. 1999;171:34–37.

    CAS  PubMed  Google Scholar 

  14. Bennett G, Higgins D. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94:1179–1190.

    Article  CAS  PubMed  Google Scholar 

  15. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia. I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411.

    Article  CAS  PubMed  Google Scholar 

  16. Darke S, Ross J. Overdose risk perceptions and behaviours among heroin users in Sydney, Australia. Eur Addict Res. 1997;3:87–92.

    Google Scholar 

  17. Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313:402.

    CAS  PubMed  Google Scholar 

  18. McGregor C, Darke S, Christie P, Ali R. Experience of non-fatal overdose among heroin users in Adelaide: circumstances and risk perception. Addiction. 1998;93:701–711.

    Article  CAS  PubMed  Google Scholar 

  19. Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction. 1999;94:71–82.

    Article  CAS  PubMed  Google Scholar 

  20. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95:687–695.

    Article  CAS  PubMed  Google Scholar 

  21. Cherubin C, McCusker J, Baden M, Kavaler F, Amsel Z. The epidemiology of death in narcotic addicts. Am J Epidemiol. 1972;96:11–22.

    CAS  PubMed  Google Scholar 

  22. Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992–1996. Drug Alcohol Depend. 2000;60:141–150.

    Article  CAS  PubMed  Google Scholar 

  23. Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKegany N. Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health. 1993;47:59–63.

    Article  CAS  PubMed  Google Scholar 

  24. Hall W, Darke S. Trends in opiate overdose deaths in Australia, 1979–1995. Drug Alcohol Depend. 1998;52:71–77.

    Article  CAS  PubMed  Google Scholar 

  25. McGregor C, Ali R, Lokan R, Christie P, Darke S. Accidental fatalities among heroin users in South Australia, 1994–1997: toxicological findings and circumstances of death. Addict Res. 2002;26:335–346.

    Article  Google Scholar 

  26. Zador D, Sunjic S, Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996;164:204–207.

    CAS  PubMed  Google Scholar 

  27. Harlow KC. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976–1987. Public Health Rep. 1990;195:455–462.

    Google Scholar 

  28. Ruttenber AJ, Luke JL. Heroin-related deaths: new epidemiologic insights. Science. 1984;226:14–20.

    CAS  PubMed  Google Scholar 

  29. Caplehorn JRM, Dalton SYN, Cluff MC, Petrenas AM, Retention in methadone maintenance and heroin addicts’ risk of death. Addiction. 1994;89:203–207.

    Article  CAS  PubMed  Google Scholar 

  30. Davoli M, Perucci CA, Forastiere F,et al. Risk factors for overdose mortality: a case control study within a cohort of intravenous drug users. Int J Epidemiol.1993;22:273–277.

    CAS  PubMed  Google Scholar 

  31. Fugelstad A, Rajs J, DeVerdier MG. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction. 1995;90:711–716.

    Article  CAS  PubMed  Google Scholar 

  32. Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). J Subst Abuse Treat. 2002;22:1–9.

    Article  PubMed  Google Scholar 

  33. Goldberger BA, Cone EJ, Grant TM, Caplan YH, Levine BS, Smialek JE. Disposition of heroin and its metabolites in heroin related deaths. J Anal Toxicol. 1994;18:22–28.

    CAS  PubMed  Google Scholar 

  34. Monforte JR. Some observations concerning blood morphine concentrations in narcotic addicts. J Forensic Sci. 1977;22:718–724.

    CAS  PubMed  Google Scholar 

  35. Risser D, Honigschnabl S, Stichenwirth M, et al. Drug-related emergencies and drug-related deaths in Vienna, 1995–1997. Drug Alcohol Depend. 2001;61:307–313.

    Article  CAS  PubMed  Google Scholar 

  36. Steentoft A, Worm K, Christenson H, Morphine concentrations in autopsy material from fatal cases after intake of morphine and/or heroin. J Forensic Sci Soc. 1988;28:87–94.

    Article  CAS  PubMed  Google Scholar 

  37. Gutierrez-Cebollada J, De La Torre R, Ortuno J, Garces J, Cami J. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend. 1994;35:169–174.

    Article  CAS  PubMed  Google Scholar 

  38. Ruttenber AJ, Kalter HO, Santinga P. The role of ethanol abuse in the etiology of heroin-related death. J Forensic Sci. 1990;35:891–900.

    CAS  PubMed  Google Scholar 

  39. Caplehorn J. Risk factors for non-HIV-related deaths among methadone maintenance patients. Eur Addict Res. 1996;2:49–52.

    Google Scholar 

  40. Richards RG, Reed D, Cravey RH. Death from intravenously administered narcotics: a study of 114 cases. J Forensic Sci. 1976;21:467–482.

    CAS  PubMed  Google Scholar 

  41. Darke S, Ross J. The use of antidepressants among injecting drug users in Sydney, Australia. Addiction. 2000;95:407–417.

    Article  CAS  PubMed  Google Scholar 

  42. Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54:155–161.

    Article  CAS  PubMed  Google Scholar 

  43. Desmond DP, Maddux JF, Trevino A. Street heroin potency and deaths from overdose in San Antonio. Am J Drug Alcohol Abuse. 1978;5:39–49.

    CAS  PubMed  Google Scholar 

  44. Risser D, Uhl A, Stichenwirth M, et al. Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction. 2000;95:375–382.

    Article  CAS  PubMed  Google Scholar 

  45. Coomber R. How often does the adulteration/dilution of heroin actually occur? An analysis of 228 “street” heroin samples across the UK (1995–96) and discussion of monitoring policy. Int J Durg Policy. 1997;8:178–186.

    Google Scholar 

  46. Coomber R. The cutting of heroin in the United States in the 1990s. J Drug Issues. 1999;29:17–36.

    Google Scholar 

  47. Maher L, Swift W, Dawson M. Heroin purity and composition in Sydney, Australia. Drug Alcohol Rev. 2001;20:439–448.

    Article  Google Scholar 

  48. Darke S, Sunjic S, Zador D, Prolov T. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 1997;47:45–53.

    Article  CAS  PubMed  Google Scholar 

  49. Kintz P, Mangin P, Lugnier AA, Chaumont AJ. Toxicological data after heroin overdose. Hum Toxicol. 1989;8:487–489.

    Article  CAS  PubMed  Google Scholar 

  50. Darke S, Hall W, Kaye S, Ross J, Duflou J. Hair morphine concentrations of fatal heroin overdose cases and living heroin users. Addiction. 2002;97:977–984.

    Article  PubMed  Google Scholar 

  51. Tagliaro F, Debattisti Z, Smith FP, Marigo M. Death from heroin overdose: findings from hair analysis. Lancet. 1998;351:1923–1925.

    Article  CAS  PubMed  Google Scholar 

  52. Kronstrand R, Grundin R, Jonsson J. Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose. Forensic Sci Int. 1998;92:29–38.

    Article  CAS  PubMed  Google Scholar 

  53. Darke S, Kaye S, Finlay-Jones R. Drug use and injection risk-taking among prison methadone maintenance patients. Addiction. 1998;93:1169–1175.

    Article  CAS  PubMed  Google Scholar 

  54. Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316:426–428.

    CAS  PubMed  Google Scholar 

  55. Seymour A, Oliver JS, Black M. Drug-related deaths among recently released prisoners in the Strathelyde region of Scotland J Forensic Sci. 2000;45:649–654.

    CAS  PubMed  Google Scholar 

  56. Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict. 1999;8:148–160.

    Article  CAS  PubMed  Google Scholar 

  57. Neaigus A, Miller M, Friedman S, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96:847–860.

    Article  CAS  PubMed  Google Scholar 

  58. Perez-Jimenez JP, Robert MS. Transitions in the route of heroin use. Eur Addict Res. 1997;3:93–98.

    Article  Google Scholar 

  59. Darke S, Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992–1996. Addiction. 2000;95:596–599.

    Google Scholar 

  60. Dinwiddie SH, Reich T, Cloninger CR. Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry. 1992;53:364–369.

    CAS  PubMed  Google Scholar 

  61. Darke S, Ross J. Poly drug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48:135–141.

    Article  CAS  PubMed  Google Scholar 

  62. Kosten TR, Rounsaville BJ. Suicidality among opioid addicts: a 2.5 year follow-up. Am J Drug Alcohol Abuse. 1998;14:357–369.

    Google Scholar 

  63. Hulse GK, English DR, Milne E, Holman CDJ. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94:221–229.

    Article  CAS  PubMed  Google Scholar 

  64. Neale J. Suicidal intent in non-fatal illicit drug overdose. Addiction. 2000;95:85–93.

    Article  CAS  PubMed  Google Scholar 

  65. Rossow I, Lauritzen G. Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction. 1999;94:209–219.

    Article  CAS  PubMed  Google Scholar 

  66. Darke S, Ross J. The relationship between suicide and overdose among methadone maintenance patients in Sydney, Australia. Addiction. 2001;96:1443–1453.

    Article  CAS  PubMed  Google Scholar 

  67. Kjelsberg E, Winther M, Dahl AA. Overdose deaths in young substance abusers: accidents or hidden suicides. Acta Psychiatr Scand 1995;91:236–242.

    CAS  PubMed  Google Scholar 

  68. Darke S, Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction. 2002;97:1383–1394.

    Article  PubMed  Google Scholar 

  69. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia. II. Responses to overdose. Addiction. 1996;91:413–417.

    Article  CAS  PubMed  Google Scholar 

  70. Strang J, Best D, Man L, Noble A, Gossop M. Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation. Int J Drug Policy. 2000;11:437–445.

    Article  PubMed  Google Scholar 

  71. Manning FJ, Ingraham LH, Derouin EM, Vaughn MS, Kukura FC, St Michel GR. Drug “overdoses” among US soldiers in Europe, 1978–1979. II. Psychological autopsies following deaths and near-deaths. Int J Addict. 1983;18:153–156.

    CAS  PubMed  Google Scholar 

  72. Garriot JC, Sturner WQ. Morphine concentrations and survival periods in acute heroin fatalities. N Engl J Med. 1973;289:1276–1278.

    Article  Google Scholar 

  73. Nakamura GR. Toxicological assessments in acute heroin fatalities. Clin Toxicol. 1978; 13:75–87.

    Article  CAS  PubMed  Google Scholar 

  74. Bammer G, Sengoz A. Non-fatal heroin overdoses. Med J Aust. 1994;161:572–573.

    CAS  PubMed  Google Scholar 

  75. McGregor C, Ali R, Christie P, Darke S. Overdose among heroin users: evaluation of an intervention in South Australia. Addict Res. 2001;9:481–501.

    Google Scholar 

  76. Darke S, Hall W. The distribution of naloxone to heroin users. Addiction. 1997;92:1195–1199.

    Article  CAS  PubMed  Google Scholar 

  77. Lenton S, Hargreaves K. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263.

    CAS  PubMed  Google Scholar 

  78. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: is there a case for takehome naloxone? BMJ. 1996;312:1435.

    CAS  PubMed  Google Scholar 

  79. Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Proventing and curtailing injecting drug use: a review of opportunities for developing and delivering “route transition interventions” Drug Alcohol Rev. 1999;18:441–445.

    Article  Google Scholar 

  80. Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000;337–346.

  81. Kemmesies UE. The Open Drug Scene and the Safe Injection Rooms Offers in Frankfurt am Main 1995. Frankfurt, Germany: Stadt Frankfurt/Dezernat Frauen und Gesundheit; 1999.

    Google Scholar 

  82. Poschadel S, Hoger R, Schnitzler J, Schreckenberg D. Evaluation der Arbeit der Drogenkonsumraume in der Bundesrepublik Deutschland. Bochum, Germany: ZEUS GmbH; 2002.

    Google Scholar 

  83. Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation for alley-rooms I, II and II in Basel. Soc Prev Med. 1996;S58–S68.

  84. Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription. Lancet. 2001;358:1417–1420.

    Article  CAS  PubMed  Google Scholar 

  85. Hall W. Assessing the Population-Level Impact of the Swiss Model of Heroin Prescribing. Sydney, Australia: University of New South Wales, Sydney; 1999. National Drug and Alcohol Research Centre Technical Report 76.

    Google Scholar 

  86. Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction. 2002;97:963–967.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shane Darke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Darke, S., Hall, W. Heroin overdose: Research and evidence-based intervention. J Urban Health 80, 189–200 (2003). https://doi.org/10.1093/jurban/jtg022

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1093/jurban/jtg022

Keywords

Navigation